Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ClearBridge Investments is a leading global equity asset manager and financial services firm, managing over $195 billion in assets for institutional and retail clients. Known for its fundamental, bottom-up stock picking, the firm invests across a broad array of sectors, including healthcare and biotech. However, ClearBridge itself does not discover, develop, or produce drugs, therapies, or medical products, and does not have its own therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ClearBridge Investments.